Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2023 | Logistical hurdles facing mobile stroke unit implementation

James Grotta, MD, Memorial Hermann-Texas Medical Center, Houston, TX, delves into the potential of mobile stroke units. These services enable faster and more frequent thrombolytic treatment, resulting in improved outcomes and long-term cost-effectiveness. While the effectiveness of mobile stroke units has been clearly demonstrated, their implementation in the US faces a funding challenge, as they don’t fit the typical insurance categories funded by companies like Medicaid. This necessitates congress legislation to overcome this financial hurdle. The potential funding of mobile stroke units in the US could serve as a catalyst for global expansion, consequently leading to more effective stroke care worldwide. This interview took place at the World Stroke Congress (WSC) 2023 in Toronto, Canada.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


James Grotta reports the following disclosures: I am on the scientific advisory board for Acticor, and am U.S. Principle Investigator for the ACTISAVE study. Acticor manufactures Glenzocimab. I am a consultant for Frazer Ltd, a company that manufactures Mobile Stroke Units.